This common medicine could be making you age faster, scientists say
The study, published in JAMA Open Network, concludes that high exposure to anticholinergic drugs used for treating chronic obstructive pulmonary disease, bladder illnesses and Parkinson's is associated with a faster decline in physical performance in older age.
Anticholinergic drugs block the action of the nerve-to-nerve signalling molecule acetylcholine, which plays a key role in the functioning of the nervous system. By inhibiting acetylcholine, these drugs affect several key bodily functions controlled by the nervous system. Their sedative and cognitive adverse effects, though, can be reversed with discontinuation.
It is not completely clear if their prolonged use is linked to sustained reduced physical function, researchers say.
Previous studies indicate that regular consumption of anticholinergics may have a constant effect over time, meaning all past exposure may show the same effect on the current risk of physical decline.
The latest study assesses the effects of cumulative exposure to the drugs over a decade, accounting for varying intensity, duration and timing of past intake.
Researchers monitored changes in walking speed and grip strength of over 4,000 older adults over time and compared this with their exposure to anticholinergic medications based on data collected from February 1994 to March 2020. While grip strength appeared unaffected, a higher exposure to anticholinergics was linked to a greater decline in walking speed.
'Higher anticholinergic exposure was associated with accelerated decline in physical performance,' scientists wrote.
'The accumulation of loss over time can become clinically meaningful.'
These findings are significant as frailty and changes in balance and gait are increasingly linked to multiple measures of poor health outcomes, including disability and mortality.
Researchers call for minimising the prescription of anticholinergic medication to promote healthy ageing.
'We provide novel findings by considering time-varying anticholinergic exposure and examining the annual change rate of physical performance,' they wrote in the study. 'Anticholinergics are associated with numerous adverse outcomes in older adults. Therefore, it is essential for clinicians to avoid their use whenever possible, prescribe the lowest effective dose and periodically reevaluate patients to identify de-prescribing opportunities to minimise potential harms.'
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
The Guardian
41 minutes ago
- The Guardian
Demand for weight loss drugs is becoming unsustainable, say pharmacists
Demand for weight loss drugs is becoming so 'unsustainable' that demand may soon outstrip supply, pharmacists have warned. The National Pharmacy Association (NPA) said supply problems could encourage people to turn to unregulated online sources, despite the risks involved. The number of people in the UK using drugs such as Wegovy and Mounjaro has soared to well above a million, with most patients paying to get them privately. During April, 1.6m packs of Mounjaro and Wegovy were bought in Britain, with the number thought to correlate closely with the number of people using them. 'Spiralling demand for weight loss medication risks going far beyond what is clinically deliverable', the NPA said. The drugs might need to be reserved for those in greatest need because they are so overweight instead of being given to the 'worried well', it added. New polling has found that 21% of Britons have tried to get hold of the medications over the past year, a figure that rises to 35% among 18- to 34-year-olds. The same survey found that 41% of all age groups would use them if they were free on the NHS. This figure rose to 64% among those aged 25-34. Savanta interviewed a representative sample of 2,002 adults aged 18 or over online from 20-23 June for the NPA, which represents 6,000 independent pharmacies. 'Weight loss jabs are one of the biggest drug innovations this century but growing demand for weight loss treatment highlights the need to make sure this is appropriate for those who want it,' said Olivier Picard, the NPA's chair. 'It's clear from this polling that more people are interested in getting weight loss jabs than can benefit from weight loss medication.' Supply of the medicines has been hit by shortages in some parts of the UK, including for higher doses of Mounjaro, the NPA said. Supply has been restricted to some pharmacies, which has stopped some new patients from going on to the drugs. The Medicines and Healthcare products Regulatory Agency, the UK's drugs watchdog, has warned patients to obtain the drugs only with a doctor's prescription, and not from beauty parlours or websites. A Department of Health spokesperson said more people would be able to obtain 'revolutionary' weight loss jabs over the next few years. 'Weight loss drugs are a powerful tool in tackling the obesity crisis head-on as part of our 10-year health plan', they added. 'This government is committed to ensuring that more people have access to these revolutionary drugs when needed, and crucially that they are able to do so in a safe and controlled way. We will ensure that those most in need will receive treatment first.' About 220,000 people in England are due to be offered tirzepatide, a diabetes drug that promotes weight loss, over the next three years. Pharmacies already provide about 85% of all weight loss drugs and need to be closely involved in the expansion of access, Picard added. 'The government should use the massive untapped expertise and skills of pharmacists to help speed up the NHS's weight loss medication programme to millions of the most in need patients,' he said.
The Guardian
3 hours ago
- The Guardian
Demand for weight loss drugs is becoming unsustainable, say pharmacists
Demand for weight loss drugs is becoming so 'unsustainable' that demand may soon outstrip supply, pharmacists have warned. The National Pharmacy Association (NPA) said supply problems could encourage people to turn to unregulated online sources, despite the risks involved. The number of people in the UK using drugs such as Wegovy and Mounjaro has soared to well above a million, with most patients paying to get them privately. During April, 1.6m packs of Mounjaro and Wegovy were bought in Britain, with the number thought to correlate closely with the number of people using them. 'Spiralling demand for weight loss medication risks going far beyond what is clinically deliverable', the NPA said. The drugs might need to be reserved for those in greatest need because they are so overweight instead of being given to the 'worried well', it added. New polling has found that 21% of Britons have tried to get hold of the medications over the past year, a figure that rises to 35% among 18- to 34-year-olds. The same survey found that 41% of all age groups would use them if they were free on the NHS. This figure rose to 64% among those aged 25-34. Savanta interviewed a representative sample of 2,002 adults aged 18 or over online from 20-23 June for the NPA, which represents 6,000 independent pharmacies. 'Weight loss jabs are one of the biggest drug innovations this century but growing demand for weight loss treatment highlights the need to make sure this is appropriate for those who want it,' said Olivier Picard, the NPA's chair. 'It's clear from this polling that more people are interested in getting weight loss jabs than can benefit from weight loss medication.' Supply of the medicines has been hit by shortages in some parts of the UK, including for higher doses of Mounjaro, the NPA said. Supply has been restricted to some pharmacies, which has stopped some new patients from going on to the drugs. The Medicines and Healthcare products Regulatory Agency, the UK's drugs watchdog, has warned patients to obtain the drugs only with a doctor's prescription, and not from beauty parlours or websites. A Department of Health spokesperson said more people would be able to obtain 'revolutionary' weight loss jabs over the next few years. 'Weight loss drugs are a powerful tool in tackling the obesity crisis head-on as part of our 10-year health plan', they added. 'This government is committed to ensuring that more people have access to these revolutionary drugs when needed, and crucially that they are able to do so in a safe and controlled way. We will ensure that those most in need will receive treatment first.' About 220,000 people in England are due to be offered tirzepatide, a diabetes drug that promotes weight loss, over the next three years. Pharmacies already provide about 85% of all weight loss drugs and need to be closely involved in the expansion of access, Picard added. 'The government should use the massive untapped expertise and skills of pharmacists to help speed up the NHS's weight loss medication programme to millions of the most in need patients,' he said.
Telegraph
5 hours ago
- Telegraph
Neanderthals loved to eat maggots, study finds
Neanderthals loved eating maggots and were not the total carnivores people often believed they were, a study has found. It has long been believed that Neanderthals, the ancient cousin species of human ancestors, ate almost nothing but meat in a similar way to lions or wolves. But a study has found this to be incorrect and proves that Neanderthals instead dined largely on maggot-riddled meat. The meat from successful hunts would be stashed and inevitably left to fester but the maggots which took root were also likely a staple of their diet, new analysis has found. Previous studies of Neanderthal remains have shown they had the same chemicals in their bones as hypercarnivore predators, which is indicative of a purely carnivorous diet. This, combined with the knowledge that Neanderthals hunted animals such as mammoths, bison, deer and reindeer, led to the widespread assumption that Neanderthals ate almost nothing but meat. But Dr Melanie Beasley, an anthropologist at Purdue University in Indiana, US, suspected this to be incorrect and studied maggots feasting on human remains to see if they could account for the chemical signature which implies a carnivore diet. Analysis found that when a carcass rots the muscles themselves become only marginally enriched with the specific form of nitrogen found in Neanderthal remains. But when maggots eat the flesh and themselves are consumed these can be up to 43 per cent richer in the nitrogen which scientists have previously thought proved carnivore behaviour. 'We suggest that the nitrogen values are inflated, perhaps substantially so, because these dedicated hunters of large mammals would have stored or cached portions of their kills for later use to compensate for unpredictable returns,' the study team wrote. 'Backup reserves of animal foods, either as packets of processed meat and fat, or as partial or complete carcasses, would have been placed in expedient above-ground rock or log cairns, suspended from tree branches or placed on above-ground racks or stages, immersed in ponds and swamps, or buried in below-ground pits. 'Such reserves, whether fresh, dried, or smoked, readily attracted flies while they were being processed, and, over the use life of the reserve, the contents almost inevitably began to putrefy and become infested with maggots.' This slowly rotting meat which was being devoured by maggots could have been eaten weeks, months, or even years after it was first hunted, the scientists concluded. Human bodies buried for study To gauge what nutrients maggots contained the scientists buried 34 human bodies donated for research at the Body Farm facility of the University of Tennessee. After two years, the maggots were studied and it was found that they were the likely reason for the high nitrogen content in Neanderthal remains that led to the assumption they were almost exclusively carnivores. Another factor in the scientists' conclusion about the Neanderthal diet is that it is impossible for a human body to survive for very long if it is consuming more than 300g of protein a day. Prolonged exposure to a diet beyond this, which is around 1,200 calories of pure protein, can lead to 'rabbit starvation' in which the body begins to shut down. This biological incompatibility with the protein-heavy diet and the maggot nitrogen finding are strong evidence that the Neanderthal was not a hypercarnivore like lions, the scientists say. 'A lion, on average, consumes anywhere from double to four-and-a-half times more protein per kg of body weight than the absolute maximum a Late Pleistocene hominin would be capable of tolerating,' the scientists wrote. The Neanderthal diet was likely to have included tongue, ribs, briskets, entrails, kidneys and other internal organs, and probably also the brain, the scientists believe. 'Fascination' of hypercarnivore image But Dr Beasley believes Neanderthals 'often ate these fat-rich tissues in a tainted or putrefied state together with their almost inevitable infestation of living and dead maggots'. 'It seems very likely that Late Pleistocene hominins would often have found themselves consuming animal foods from tainted or putrefied reserves laced with living and dead maggots,' she told The Telegraph. 'I think for a long time the hypercarnivore narrative about Neanderthals has been wrong but that image adds to their exceptionalism and fascination, so that narrative has persisted. 'Hominins ate meat regularly starting with Homo erectus, but they ate a diversity of other foods too. 'We are just saying that we need to consider those other dietary inputs like the inevitable stored foods laced with fatty maggots that would have been nutritionally beneficial.'
